Jeffrey T Blue

Title: The Innovative Contributions of Jeffrey T Blue

Introduction

Jeffrey T Blue is a notable inventor based in Telford, PA (US), recognized for his significant contributions to the field of vaccine development. With a total of seven patents to his name, he has made strides in formulating effective dengue virus vaccine compositions. His work is pivotal in addressing public health challenges associated with dengue fever.

Latest Patents

Among his latest patents, Jeffrey T Blue has developed formulations of dengue virus vaccine compositions. These formulations include at least one live, attenuated dengue virus or live, attenuated chimeric flavivirus, combined with a buffer, a sugar, a cellulose derivative, a glycol or sugar alcohol, and optionally an alkali or alkaline salt and an amino acid. Another notable patent involves formulations that comprise a sugar of at least 150 mg/ml, a carrier, and similar components, showcasing his innovative approach to vaccine formulation.

Career Highlights

Throughout his career, Jeffrey T Blue has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. His experience in these organizations has contributed to his expertise in vaccine research and development.

Collaborations

Jeffrey has collaborated with esteemed colleagues such as Jon H Condra and Rose M Cubbon, further enhancing the impact of his work in the field of vaccine innovation.

Conclusion

Jeffrey T Blue's contributions to vaccine development, particularly in formulating dengue virus vaccines, highlight his role as a key innovator in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing public health through scientific research and innovation.